Certe
Certe is a Northern Netherlands medical diagnostics organization providing clinical chemistry, microbiology, point-of-care testing, and function examinations to hospitals, general practitioners, midwives, and patients under contracted Dutch health insurance reimbursement.
- Company typePrivate
- Founded2012
- HeadquartersGroningen, Netherlands
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Certe does
Certe is an integrated medical diagnostics and advisory organization serving primary and secondary healthcare providers across Northern Netherlands. Founded in 2012 and headquartered in Groningen, the company operates a regional network of blood collection and examination locations spanning Groningen, Drachten, Assen, Winschoten, and Leeuwarden, with an additional laboratory under construction in Drachten. Its service portfolio spans clinical chemistry, medical microbiology, point-of-care testing, and a comprehensive function examination suite (Holter, ambulatory blood pressure, event recording, fundus photography, lung function, flow-volume), augmented by specialized chronic disease programs in anticoagulation (Trombosedienst and the Transmuraal Trombose Expertisecentrum Noord-Nederland), asthma/COPD, cardiovascular risk, and diabetes, plus the Tropaz patient app for INR self-monitoring.
Underlying technology is anchored by the GLIMS2025 Laboratory Information System running on Linux — described as the largest LIS project in the Netherlands and a Dutch-first deployment — which integrates Certe's diagnostic workflows with referring hospitals, general practitioners, midwives, and institutional partners including UMCG and CerUM. The organization holds formal accreditation for medical diagnostic quality standards.
Commercially, Certe generates revenue under contracted annual rates with Dutch health insurers (zorgverzekeraars), functioning as a subscription-style recurring reimbursement model tied to covered diagnostic services. Go-to-market is sales-led, with healthcare providers acting as referral sources and patients self-scheduling through an online booking platform. The company serves hospitals (secondary care), general practitioners and midwives (primary care), and by extension hundreds of thousands of patients, having completed approximately fifteen million patient interactions to date.
Certe firmographics
Firmographics- Name
- Certe
- Legal name
- Certe
- Website
- https://certe.nl
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Certe is a Northern Netherlands medical diagnostics organization providing clinical chemistry, microbiology, point-of-care testing, and function examinations to hospitals, general practitioners, midwives, and patients under contracted Dutch health insurance reimbursement.
- Ownership category
- akta.pro rank
Certe industry classification
Industry- Product category
- Medical Diagnostic Laboratory Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
- akta.pro secondary industries
- Pulmonary Function & Respiratory Diagnostic Centers (PFT/Spirometry) (HLAFAKAJ), Quality Management & Regulatory Compliance (CLIA/CAP/ISO) for Labs (HLACAMAH)
Keywords
Where Certe is headquartered
LocationHeadquarters
- HQ city
- Groningen
- HQ country
- Netherlands
- HQ region
- Europe
Offices5 records
Markets served
Certe business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Medical Diagnostic Services: Certe provides integral medical diagnostics and advice for first-line and second-line healthcare. They deliver medical diagnostics and derived products and services for healthcare providers and their patients, including hospitals, general practitioners, midwives, and ultimately hundreds of thousands of patients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Contracted healthcare services covered by Dutch health insurance |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Certe product offering
Product offeringCore offering
Certe provides integrated medical diagnostics and advisory services for primary and secondary healthcare in the Netherlands. The organization operates clinical laboratory services including blood collection, clinical chemistry, medical microbiology, and point-of-care testing, alongside specialized chronic disease management services (Thrombosis, Asthma/COPD, Cardiovascular Risk, Diabetes) and function examinations (ECG, blood pressure monitoring, lung function testing). It runs its own Laboratory Information System (GLIMS2025 on Linux) and serves hospitals, general practitioners, midwives, and patients across Northern Netherlands.
Product overview
Certe is an organization for integrated medical diagnostics and advisory services for primary and secondary healthcare in Northern Netherlands. The core offering consists of laboratory diagnostic services including blood collection, clinical chemistry, medical microbiology, and point-of-care testing, complemented by specialized services such as the Thrombosis Service (with self-measurement support via Tropaz app), Asthma/COPD Service, Cardiovascular Risk Service, and Diabetes Service. Function examinations include 24-hour ECG (Holter), 24-hour blood pressure monitoring (ABPM), event recording, fundus photography, lung function testing, and flow-volume curves. The organization operates its own Laboratory Information System (GLIMS2025 on Linux) and maintains multiple patient service locations across the region.
Differentiator
Problem solved
Functional benefit
Brands
- Tropaz: App used by patients for self-monitoring INR values and receiving dosage instructions from the Trombosedienst (Anticoagulation Service). Patients can input their values and receive dose calendars through the app.
Products and services
- Bloedafname (Blood Collection) Blood collection services for diagnostic testing, available at multiple locations including hospitals and primary care facilities across Northern Netherlands.
- Klinische Chemie (Clinical Chemistry) Laboratory analysis of blood and body fluids for chemical markers, enzymes, and metabolic parameters to support clinical decision-making.
- Medische Microbiologie (Medical Microbiology) Diagnostic testing for infectious diseases, including analysis of bacteria, parasites, fungi, and viruses in clinical samples.
- Point-of-Care Testing (POCT) Rapid diagnostic tests performed at or near the patient's location for immediate results, supporting clinical workflows in primary care.
- Trombosedienst (Thrombosis Service / Anticoagulation Service) Anticoagulation management service that monitors patients on blood-thinning medications, including self-measurement support via the Tropaz app and regional dose advice.
- Transmuraal Trombose Expertisecentrum Noord-Nederland Regional thrombosis expertise center serving Northern Netherlands, providing specialized anticoagulation care across organizational boundaries.
- 24-uurs ECG (Holter) 24-hour continuous electrocardiogram monitoring to detect heart rhythm abnormalities, performed as a function examination for primary care referrals.
- 24-uurs bloeddrukmeting (ABPM) 24-hour ambulatory blood pressure monitoring used for the diagnosis and management of hypertension.
- Eventrecording Cardiac event monitoring for intermittent heart rhythm disturbances, ordered by primary care physicians.
- Fundusfotografie (Fundus Photography) Diagnostic imaging of the retina used for screening and monitoring of ophthalmic conditions in primary care.
- Longfunctieonderzoek (Lung Function Testing) Pulmonary function tests including spirometry for respiratory assessment, supporting diagnosis of asthma, COPD, and other lung conditions.
- Flowvolume-curve (with/without reversibility) Spirometry test with or without reversibility testing, used in the diagnosis of asthma and COPD.
- Certe Astma-/COPD-dienst Specialized diagnostic and management service for patients with asthma and COPD, combining function tests with clinical advice.
- Certe CVR-dienst (Cardiovascular Risk Service) Cardiovascular risk assessment and management service combining diagnostics with preventive clinical advice for at-risk patients.
- Certe Diabetesdienst Diabetes-related diagnostic and monitoring service supporting GPs in the management of diabetic patients.
- SOA-onderzoek (STI Testing) Sexually transmitted infection testing services offered as a dedicated diagnostic examination under medical microbiology.
- Urineonderzoek (Urine Testing) Urine analysis for a range of medical conditions, performed as part of routine and specialized diagnostics.
- Ontlastingsonderzoek (Stool Testing) Fecal testing for digestive disorders and infections.
- Sperma-onderzoek (Semen Analysis) Semen analysis used in fertility assessment, offered through primary care referrals.
- Sputumonderzoek (Sputum Testing) Sputum analysis for respiratory infections and related conditions.
- Uitstrijk (Smear Test) Cytological smear testing for diagnostic purposes, including cervical screening.
Companies that use Certe
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Certe technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Certe partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Pranger-Rosier InstallatiescoreInstallation partner for the construction of the new laboratory in Drachten. Collaborating with Certe and Bouwgroep Dijkstra Draisma on this future-proof laboratory construction project.
- Bouwgroep Dijkstra DraismacoreConstruction partner for the new laboratory building in Drachten. Project leader Heerke Osinga from Bouwgroep Dijkstra Draisma is overseeing the construction which began with foundation piles in January.
- UMCG (Universitair Medisch Centrum Groningen)coreUMCG and Certe have bundled forces in laboratory diagnostics for faster clarity for patients. This collaboration aims to create a better and faster care process.
- CerUMcoreCollaboration with CerUM has improved cooperation and shortened the patient journey for Acute Leukemia patients. This partnership demonstrates Certe's role in specialized diagnostic pathways.
- Caparis Business PostminorCerte works together with Caparis Business Post for postal delivery services, supporting the organization's administrative and communication needs.
Scale indicators3 records
Recent moves7 records
Expansion highlights4 records
Certe competitors and assessment
Company assessmentBroad incumbents
- Synlab: Europe's largest clinical diagnostics network with a Dutch footprint. Operates far more broadly than Certe but competes directly for hospital tenders and esoteric testing work in the same Dutch regions.
- Eurofins Clinical Diagnostics: Global clinical-diagnostics arm of Eurofins with extensive laboratory capabilities across Europe. Provides the kind of broad menu and scale that competing regional labs like Certe must benchmark against for hospital and specialty work.
- Unilabs: Pan-European diagnostic services provider with clinical-lab operations in multiple countries. Competes with Certe for large hospital contracts and broader esoteric testing services.
- Cerba Healthcare: European reference and specialty laboratory group offering routine and esoteric clinical diagnostics across multiple geographies. Comparable to Certe in clinical-lab category but with much larger international reach.
Direct peers
- Atalmedial: Dutch medical diagnostics organization serving primary and secondary care with blood testing, microbiology and function examinations. Closely comparable in scope, regional coverage and customer mix to Certe.
- Saltro: Dutch regional diagnostic laboratory providing blood collection, clinical chemistry, microbiology and function testing to GPs and hospitals. Direct competitor in the primary-care diagnostics market with a comparable service portfolio and contracted insurer model.
- Star-shl: Dutch diagnostics provider offering clinical chemistry, microbiology and screening programs to GPs, midwives and hospitals. Same contracted-insurer model and overlapping test menu as Certe.
- NMDL (Nederlands Moleculair Diagnostisch Laboratorium): Dutch molecular diagnostics laboratory offering specialized infectious-disease and molecular testing services. Comparable in clinical-lab category with overlap on microbiology services.
- Result Laboratorium: Dutch regional clinical laboratory providing diagnostic testing for primary and secondary healthcare providers. Directly comparable business model and customer base to Certe.
Regional players
- Medlon: Dutch regional clinical laboratory providing diagnostic services primarily in the eastern Netherlands. Comparable in service offering and customer base to Certe but operates in a different geography.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Certe social profiles
Digital presenceCerte financial estimates
Financial estimateRevenue estimate
Valuation estimate
Certe leadership team
Management profileNumber of profiles
Profiles1 record
Certe funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Certe M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Certe
What does Certe do?
Certe provides integrated medical diagnostics and advisory services for primary and secondary healthcare in the Netherlands. The organization operates clinical laboratory services including blood collection, clinical chemistry, medical microbiology, and point-of-care testing, alongside specialized chronic disease management services (Thrombosis, Asthma/COPD, Cardiovascular Risk, Diabetes) and function examinations (ECG, blood pressure monitoring, lung function testing). It runs its own Laboratory Information System (GLIMS2025 on Linux) and serves hospitals, general practitioners, midwives, and patients across Northern Netherlands.
Is Certe a public or private company?
Certe is a private company. It is classified as unknown and is currently operating.
When was Certe founded?
Certe was founded in 2012. It employs 501 to 1,000 people.
Where is Certe based?
Certe is headquartered in Groningen, Netherlands, in the Europe region.
How does Certe make money?
One revenue line is on record: medical Diagnostic Services.
Who are Certe's main competitors?
Broad incumbents on record are Synlab, Eurofins Clinical Diagnostics, Unilabs and Cerba Healthcare. Direct peers are Atalmedial, Saltro, Star-shl, NMDL (Nederlands Moleculair Diagnostisch Laboratorium) and Result Laboratorium. Medlon is listed as a regional player.
Does Certe have an API?
No public API is recorded for Certe.
What industry is Certe in?
Certe's product category is Medical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLAFAKAJ, Pulmonary Function & Respiratory Diagnostic Centers (PFT/Spirometry). Its NAICS code is 621511 and its SIC code is 8071.